Learning about: Soliqua 100/33™ and Xultophy 100/3.6™: the new once-daily injectable GLP-1 receptor agonist/basal insulin combination pens Soliqua 100/33 and Xultophy 100/3.6 are two new injectable combination products approved by the U.S. Food and Drug Administration (FDA) in November of 2016. They are used for the treatment of type 2...

Learning About Diabulimia Most people are familiar with eating disorders such as anorexia, bulimia and binge eating disorder, but few are familiar with an eating disorder that is unique to patients with type 1 diabetes (T1DM). ED-DMT1, or what the media has dubbed “diabulimia,” is an eating disorder where patients...

The Story Behind Type 1.5 Diabetes Type 1 and type 2 diabetes are the most well-known forms of diabetes. However, about 10% of people with diabetes have type 1.5 diabetes. Type 1.5 diabetes is also sometimes called LADA which stands for latent autoimmune diabetes in adults. Type 1 diabetes (T1DM)usually...

Underatnding What You Need To Know About Albuminuria And Diabetic Kidney Disease There are several disorders that are associated with diabetes: high blood pressure, high cholesterol, obesity, heart disease and kidney disease. According to the American Diabetes Association (ADA) Guidelines, kidney disease occurs in 20-40% of patients with diabetes and...

Family Planning with Type 1 Diabetes Currently, good blood glucose control during pregnancy is still a big challenge for women with type 1 diabetes (T1D). Twenty-five years ago, doctors warned women of child bearing age with T1D, becoming pregnant was too dangerous for a mother and her child. Now, women...